KURA ONCOLOGY, INC. Amortization of Debt Issuance Costs
KURA ONCOLOGY, INC. (KURA) reported Amortization of Debt Issuance Costs of $217.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-12
- KURA ONCOLOGY, INC. amortization of debt issuance costs for the quarter ending 2026-06-30 was $111.00K, a 19.57% decline year-over-year.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for the quarter ending 2026-03-31 was $106.00K, a 20.30% decline year-over-year.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for the quarter ending 2025-12-31 was $103.00K, a 26.43% decline year-over-year.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for the quarter ending 2025-09-30 was $141.00K, a 5.22% increase year-over-year.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for fiscal 2025 was $515.00K, a 1.53% decline from fiscal 2024.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for fiscal 2024 was $523.00K, a 9.64% increase from fiscal 2023.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for fiscal 2023 was $477.00K, a 553.42% increase from fiscal 2022.
- KURA ONCOLOGY, INC. amortization of debt issuance costs for fiscal 2022 was $73.00K, a 81.70% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $217.00K 10-Q · filed 2026-08-12 | $320.00K derived: sum of 3 quarters · filed 2026-08-12 | $461.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $106.00K 10-Q · filed 2026-05-12 | $209.00K derived: sum of 2 quarters · filed 2026-05-12 | $350.00K derived: sum of 3 quarters · filed 2026-05-12 | $488.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $244.00K derived: sum of 2 quarters · filed 2026-03-05 | $382.00K derived: sum of 3 quarters · filed 2026-08-12 | $515.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $141.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $279.00K derived: sum of 2 quarters · filed 2026-08-12 | $412.00K 10-Q · filed 2025-11-04 | $552.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $271.00K 10-Q · filed 2026-08-12 | $411.00K derived: sum of 3 quarters · filed 2026-08-12 | $545.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $133.00K 10-Q · filed 2026-05-12 | $273.00K derived: sum of 2 quarters · filed 2026-05-12 | $407.00K derived: sum of 3 quarters · filed 2026-05-12 | $534.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $274.00K derived: sum of 2 quarters · filed 2026-03-05 | $401.00K derived: sum of 3 quarters · filed 2026-03-05 | $523.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $261.00K derived: sum of 2 quarters · filed 2025-11-04 | $383.00K 10-Q · filed 2025-11-04 | $502.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | $127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $249.00K 10-Q · filed 2025-08-07 | $368.00K derived: sum of 3 quarters · filed 2026-03-05 | $490.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | $122.00K 10-Q · filed 2025-05-01 | $241.00K derived: sum of 2 quarters · filed 2026-03-05 | $363.00K derived: sum of 3 quarters · filed 2026-03-05 | $484.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $241.00K derived: sum of 2 quarters · filed 2026-03-05 | $362.00K derived: sum of 3 quarters · filed 2026-03-05 | $477.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $243.00K derived: sum of 2 quarters · filed 2024-11-07 | $358.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $236.00K 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | $115.00K 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | $73.00K 10-K · filed 2025-02-28 | |||
| 2021-12-31 | $399.00K 10-K · filed 2024-02-27 | |||
| 2018-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $70.00K derived: sum of 2 quarters · filed 2021-02-24 | $127.00K derived: sum of 3 quarters · filed 2021-02-24 | $184.00K 10-K · filed 2021-02-24 |
| 2018-09-30 | $53.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $110.00K derived: sum of 2 quarters · filed 2019-11-05 | $167.00K 10-Q · filed 2019-11-05 | $223.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $114.00K 10-Q · filed 2019-08-01 | $170.00K derived: sum of 3 quarters · filed 2020-02-25 | $200.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $57.00K 10-Q · filed 2019-05-07 | $113.00K derived: sum of 2 quarters · filed 2020-02-25 | $143.00K derived: sum of 3 quarters · filed 2020-02-25 | $159.00K derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $86.00K derived: sum of 2 quarters · filed 2020-02-25 | $102.00K derived: sum of 3 quarters · filed 2020-02-25 | $118.00K 10-K · filed 2020-02-25 |
| 2017-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-05 | $46.00K derived: sum of 2 quarters · filed 2018-11-05 | $62.00K 10-Q · filed 2018-11-05 | $77.00K derived: sum of 4 quarters · filed 2018-11-05 |
| 2017-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $32.00K 10-Q · filed 2018-08-06 | $47.00K derived: sum of 3 quarters · filed 2018-08-06 | $63.00K derived: sum of 4 quarters · filed 2018-08-06 |
| 2017-03-31 | $16.00K 10-Q · filed 2018-05-08 | $31.00K derived: sum of 2 quarters · filed 2018-05-08 | $47.00K derived: sum of 3 quarters · filed 2018-05-08 | |
| 2016-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $31.00K derived: sum of 2 quarters · filed 2018-03-12 | $42.00K 10-K · filed 2018-03-12 | |
| 2016-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $27.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $11.00K 10-Q · filed 2017-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |